SolarEdge Technologies, Inc. ( SEDG ) shares are trading lower after it reported first-quarter FY24 results. Revenues of $204.4 million, beating the consensus of $196.0 million. Revenues from the solar segment stood at $190.1 million, down 79% Y/Y, in the quarter. Adjusted gross margin was negative (6.5)% versus a positive margin of 32.6% in the prior year quarter. Adjusted operating loss stood at $(122.5)...

12:16 PM EDT, 05/09/2024 (MT Newswires) -- Converge Technology Solutions ( CTSDF ) on Thursday said its first-quarter adjusted net income fell 7%. The company's adjusted earnings, excluding most one-time items, dropped to $22.7 million, or $0.11 per share, from $24.4 million, or $0.12. The net loss widened to $3.5 million from $3.4 million. Revenue slid 7.3% to $628.8 million...

(Corrects in paragraph 6 to say Cigna and Optum are covering two or three Humira biosimilars) By Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. The drugmaker also...

12:16 PM EDT, 05/09/2024 (MT Newswires) -- (Updates with Spirit AeroSystems ( SPR ) and Boeing ( BA ) comments starting from the fifth paragraph and stock move in the last paragraph.) Santiago Paredes, who worked for Spirit AeroSystems ( SPR ) , regularly found anywhere from 50 to 100, 200 defects on fuselages that were being shipped to Boeing...